Company intelligence / Profile preview

Ariane Medical Systems

Alfreton, England, United Kingdomarianemedicalsystems.com ↗

Ownership: Private
Development stage: Other

Overview

Ariane Medical Systems offers the commercially available Papillon X-ray brachytherapy system, including the Papillon 50 and Papillon+, targeting rectal, breast, and skin cancers. The devices are used in several European countries and have demonstrated improved patient outcomes and reduced hospital stays for eligible cancer patients[1][5].

Therapeutic areas: Oncology
Modalities: DeviceRadiopharmaceutical
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Ariane Medical Systems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ariane Medical Systems.

Explore the full profile